J. A. Lopez-Martin

First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours

J. Tabernero, T. Yap, D. Olmos, 2012, British Journal of Cancer.

Blood-based biomarkers for monitoring antiangiogenic therapy in non-small cell lung cancer

L. Paz-Ares, M. T. Agulló-Ortuño, J. López-Martín, 2016, Medical Oncology.

Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer

J. Rodríguez-Peralto, M. T. Agulló-Ortuño, J. López-Martín, 2015, Tumor Biology.